AstraZeneca Offers Online Enrollment and Additional Improvements to Patient Assistance Program
13 Janeiro 2010 - 1:45PM
PR Newswire (US)
WILMINGTON, Del., Jan. 13 /PRNewswire-FirstCall/ -- AstraZeneca
(NYSE: AZN) announced today that enrollment and re-enrollment for
two of its prescription savings programs is available online for
the first time at http://www.azandme.com/. In addition, online
self-service options are available for both programs, which enable
health care providers, advocates and patients to order and monitor
the shipping of refills and check the status of their enrollment
online at http://www.azandme.com/. AstraZeneca is the first
pharmaceutical company to provide these self-service options
directly to patients. "We are using more tools to help patients get
the medicines and information they need in an efficient and timely
way," said Jennifer McGovern, AstraZeneca Director of Patient
Assistance Programs. "We hope to be able to better serve patients
and the people who support them by continually making program
enhancements." For over 30 years, AstraZeneca has offered patient
assistance, because the company knows that medicines can only make
a difference if patients can access them. Web-based improvements
are another way that AstraZeneca is strengthening its commitment to
patient health. Program Details To learn more about the program,
get a list of available medicines, or to see if you qualify for an
AZ&Me(TM) Prescription Savings program, please call
1-800-AZandMe (292-6363) or visit http://www.azandme.com/.
Assistance specialists are available Monday through Friday between
8 AM and 6 PM EST. For those who prefer completing a hard-copy
application, the AZ&Me(TM) Prescription Savings program for
people without insurance and for people with Medicare Part D now
also offers one streamlined application for both programs. The
application is available in English and Spanish at
http://www.azandme.com/ or by calling 1-800-AZandMe (292-6363).
Prescription savings programs are available regardless of which
medications doctors prescribe. To find out more about the more than
475 savings programs covering 2,500 medications, please visit
http://www.pparx.org/ or call 1-888-4PPA-NOW (1-888-477-2669).
NOTES TO EDITORS: About AstraZeneca AstraZeneca is engaged in the
research, development, manufacturing and marketing of meaningful
prescription medicines and in the supply of healthcare services.
AstraZeneca is one of the world's leading pharmaceutical companies
with global healthcare sales of $ 31.6 billion and is a leader in
gastrointestinal, cardiovascular, neuroscience, respiratory,
oncology and infectious disease medicines. In the United States,
AstraZeneca is a $13.5 billion dollar healthcare business. For more
information about AstraZeneca in the US or our AZ&Me(TM)
Prescription Savings programs, please visit:
http://www.astrazeneca-us.com/. DATASOURCE: AstraZeneca CONTACT:
Media Inquiries, Tiffany Burke of AstraZeneca, +1-302-885-4995 Web
Site: http://www.astrazeneca-us.com/
Copyright